|
|
News Breaks | | | | February 5, 2013 | | 13:30 EDT |  | PRGO | Perrigo confirms FDA approval of testosterone gel 1%
Perrigo Company (PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo's NDA included a bioequivalence study that compared its product to AbbVie's AndroGel 1%. AndroGel 1% (testosterone gel 1%) is indicated to treat adult males who have low or no testosterone. Annual sales were approximately $705M annually, as measured by Symphony Health. Perrigo's Chairman and CEO Joseph C. Papa stated, "This filing is another example of our investment in new products and continued focus on bringing extended topicals to market. As always, Perrigo is committed to making quality healthcare more affordable for our customers and consumers." | |
|
News For PRGO From The Last 14 Days Check below for free stories on PRGO the last two weeks. |
|
|
| June 18, 2013 | | 08:36 EDT |  | PRGO | Elan shares could be worh $19 in a buyout, says Jefferies
Jefferies raised its price target for shares of Elan (ELN) to $19 from $14, reflecting what it sees as the value of the company in a takeout scenario. The firm says Elan management suggested they would be open to sale in the $15-$20 per share range. Jefferies believes a high taxpaying suitor could pay the upper end of that range, and lists Allergan (AGN), Regeneron (REGN), Vertex (VRTX), Alexion (ALXN), Zoetis (ZTS), Mylan (MYL) and Perrigo (PRGO) as potential acquirers for Elan. Shares of Elan are up 13c to $13.62 in pre-market trading after Royalty Pharma announced that its buyout proposal for the company has expired. | | | June 17, 2013 | | 08:35 EDT | | PRGO | Perrigo acquires ophthalmic product portfolio from Fera for $93M
Perrigo announced that it has signed a definitive agreement to acquire and has completed the acquisition of an ophthalmic sterile ointment and solution product portfolio from Fera Pharmaceuticals and its affiliates. The acquired portfolio, including nine prescription ANDA products, generated more than $30M in net revenues during calendar year 2012. Terms of the transaction include an upfront cash payment of approximately $93M along with potential contingent payments totaling approximately $36M, certain of which relate to Perrigo securing additional product rights from Fera. Additionally, Perrigo expects to receive a tax benefit as a result of the acquisition, the net present value of which is estimated to be approximately $20M. This acquisition is expected to be more than 12c accretive to adjusted EPS for fiscal 2014 and more than 4c accretive to GAAP EPS after the inclusion of estimates for intangible amortization, transaction and integration related expenses. | | | June 12, 2013 | | 10:14 EDT |  | PRGO | On the Fly: Initiation Summary
AMRI (AMRI) coverage resumed with a Buy at Sterne Agee… AMRI (AMRI) re-initiated with a Buy at Sterne Agee… Allscripts (MDRX) re-initiated with a Buy at Sterne Agee… Amkor Technology (AMKR) initiated with a Buy at Sidoti… Astec (ASTE) initiated with a Hold at Stifel… Bob Evans (BOBE) initiated with an Outperform at Oppenheimer… Calumet Specialty Products (CLMT) initiated with an Outperform at Credit Suisse… Cerner (CERN) re-initiated with a Neutral at Sterne Agee… Charles River Labs (CRL) re-initiated with a Buy at Sterne Agee… Covance (CVD) re-initiated with a Buy at Sterne Agee… First Republic Bank (FRC) initiated with an Overweight at Barclays… Greenway Medical (GWAY) re-initiated with an Underperform at Sterne Agee… Gulfport Energy (GPOR) re-initiated with an Outperform at Credit Suisse… ICON plc (ICLR) re-initiated with a Neutral at Sterne Agee… Manitowoc (MTW) initiated with a Buy at Stifel… PAREXEL (PRXL) re-initiated with a Neutral at Sterne Agee… Pacific Drilling (PACD) initiated with an Outperform at Credit Suisse… Perrigo (PRGO) initiated with an Overweight at Morgan Stanley… Quality Systems (QSII) re-initiated with a Neutral at Sterne Agee… Quintiles (Q) initiated with an Underperform at Sterne Agee… Reliance Steel (RS) initiated with a Hold at Topeka… SVB Financial (SIVB) initiated with an Equal Weight at Barclays… Terex (TEX) initiated with a Buy at Stifel… Texas Roadhouse (TXRH) initiated with a Buy at BofA/Merrill… Whiting Petroleum (WLL) initiated with an In-Line at Imperial Capital… athenahealth (ATHN) re-initiated with a Neutral at Sterne Agee. | | | 07:30 EDT | | PRGO | Perrigo initiated with an Overweight at Morgan Stanley
 Subscribe for More Information | | | 07:08 EDT |  | PRGO | Drugstores ready access changes to Plan B pill, WSJ reports
Drugstores (CVS, RAD, WAG) are preparing to change how they stock and sell a widely used emergency contraceptive after the Obama administration agreed to allow the pill to be sold over the counter to customers of all ages. Sold primarily under the brand name Plan B (TEVA, ACT, PRGO), the pill is currently stocked behind pharmacy counters, reports the Wall Street Journal.Reference Link | | | 06:05 EDT | | PRGO | On the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: The tectonic plates of the world economy are shifting, moving the yield on the 10-year Treasury to the highest level in more than a year and shaking financial markets. Now, some constants are being questioned in markets, triggering paroxysms in stocks, bonds, commodities and the currencies of emerging markets, the Wall Street Journal reports...Drugstores (CVS, RAD, WAG) are preparing to change how they stock and sell a widely used emergency contraceptive after the Obama administration agreed to allow the pill to be sold over the counter to customers of all ages. Sold primarily under the brand name Plan B (TEVA, ACT, PRGO), the pill is currently stocked behind pharmacy counters, the Wall Street Journal reports...REUTERS: If currency turbulence in emerging markets becomes a full-scale investor flight, the Fed may have a new headache in deciding when to slow its dollar printing policy. The link between U.S. monetary policy and currency runs on the other side of the world could be tighter than many assume, Reuters reports...Toyota Motor (TM) said it’s unlikely to recapture its peak market share it held four years ago in the U.S. (GM, F), its biggest market, the latest sign the carmaker is shifting to improving quality from aggressively expanding sales, Reuters reports...BLOOMBERG: Exchange executives (NYX, NDAQ), long shielded from legal scrutiny in the U.S., have been put on notice that may be changing after federal regulators fined CBOE Holdings (CBOE) $6M for unprecedented lapses in supervision, Bloomberg reports...Borealis Infrastructure Management and its Kuwaiti-British partners abandoned their $8.3B bid for the U.K. water utility Severn Trent (SVTRY) as the offer deadline expired, Bloomberg reports. | | | June 11, 2013 | | 05:50 EDT | | PRGO | U.S. to now comply with ruling on morning-after pill, WSJ reports
In a reversal, the U.S. government said it would allow emergency contraceptive Plan B to be sold in drugstores without restrictions and would end an appeal in a long-running court case, reports the Wall Street Journal. Reference Link | | | June 6, 2013 | | 08:30 EDT | | PRGO | Federal appeals court orders access to contraceptive, WSJ reports
Subscribe for More Information | |
|
|
|
|
|
|
